Clinical Trial Update: Combining Low Oxygen Therapy and an Adenosine A2a Receptor Antagonist to Improve Functional Mobility After Spinal Cord Injury [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating whether combining low oxygen therapy with an adenosine A2a receptor antagonist can improve functional mobility after sp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelopathy
• Spinal Cord Injury

Drugs mentioned

• Adenosine A2A receptor antagonist (Adenosine A2A receptor antagonist)

Snippet

Sponsor: Randy Trumbower, PT, PhD | Conditions: Spinal Cord Injuries, Myelopathy | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING